NEO Battery Materials Increases Share Ownership of South Korean Subsidiary - NBM Korea Co.

T S X V : NBM ) ( OTCQB: NBMFF )

NEO Battery Materials Ltd. (" NEO " or the " C o mpan y "), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, announces that the Company has increased its ownership of the South Korean subsidiary, NEO Battery Materials Korea Co., Ltd. (" NBM Korea "), through a Share Purchase Agreement (the " Agreement ") with Automobile & PCB Inc (" A&P ").

NEO acquired 258,829 Common Shares of NBM Korea from A&P for an aggregate purchase price of $1,708,707 CAD (the " Transaction "). Preceding the Transaction, the Company directly held 776,487 Common Shares of NBM Korea, representing 60% of the issued and outstanding shares of NBM Korea, and following the closing, NEO now directly holds 1,035,316 Common Shares, representing 80% of the issued and outstanding shares of NBM Korea. The Transaction has closed on January 29, 2024.

Considering recent technological advancements and breakthroughs at the R&D Scale-Up Centre in South Korea, the Board of Directors has unanimously resolved that acquiring the Common Shares of NBM Korea was mandatory to serve the Company's best interests. Greater ownership will effectively translate into expanded proportions of short- and long-term value creation/realization and future cash flows for NEO's shareholders.

Furthermore, NBM Korea is actively discussing with several South Korean venture capital and institutional funds for further expansion and scale-up funding for the silicon anode business and value-enhancing battery technology projects. Accredited last October, NBM Korea's Innovative Growth Venture Enterprise Certification has enabled institutional investors to participate in NBM Korea's offerings due to the rigorous due diligence completed by the Ministry of SMEs and Startups of South Korea. In the long term, management intends to publicly offer or list NBM Korea's Common Shares in the South Korean stock exchange.

About NEO Battery Materials Ltd.
NEO Battery Materials is a Canadian battery materials technology company focused on developing silicon anode materials for lithium-ion batteries in electric vehicles, electronics, and energy storage systems. With a patent-protected, low-cost manufacturing process, NEO Battery enables longer-running and ultra-fast charging batteries compared to existing state-of-the-art technologies. The Company aims to be a globally-leading producer of silicon anode materials for the electric vehicle and energy storage industries. For more information, please visit the Company's website at: https://www.neobatterymaterials.com/ .

On Behalf of the Board of Directors
Spencer Sung Bum Huh
Director, President, and CEO
shuh@neobatterymaterials.com

For Investor Relations, PR & More Information:
Danny Huh
SVP, Strategy & Operations
info@neobatterymaterials.com

This news release includes certain forward-looking statements as well as management's objectives, strategies, beliefs and intentions. Forward-looking statements are frequently identified by such words as "may", "will", "plan", "expect", "anticipate", "estimate", "intend" and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, including the speculative nature of mineral exploration and development, fluctuating commodity prices, the effectiveness and feasibility of technologies which have not yet been tested or proven on a commercial scale, competitive risks and the availability of financing, as described in more detail in our recent securities filings available at www.sedarplus.com . Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

News Provided by GlobeNewswire via QuoteMedia

NEO Battery Materials NBM:CC TSXV:NBM Emerging Tech Investing

NBM:CC

NEO Battery Materials Appoints Renowned Battery Industry Pioneer Mr. Ricky Lee as Lead Managerial Advisor

T S X V : NBM ) ( OTC: NBMFF )

NEO Battery Materials Ltd. (" NEO " or the " C o mpan y "), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to appoint Mr. Ricky Lee, a renowned battery industry pioneer, as the Lead Managerial Advisor. Mr. Ricky Lee is a 35-year battery and energy industry executive with substantial experience with battery material and cell design, mass-production technology, and equipment & process development at globally distinguished companies.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

NEO Battery Materials Announces Appointment of Dr. Dongmok Whang as New Director

T S X V : NBM ) ( OTC: NBMFF )

NEO Battery Materials Ltd. (" NEO " or the " C o mpan y "), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce the appointment of Dr. Dongmok Whang, NEO's Lead Scientific Advisor, as a new Director of the Company.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

NEO Battery Materials Announces Change of Auditor to MNP LLP

NEO Battery Materials Ltd. (" NEO " or the " C o mpan y ") ( T S X V : NBM ) ( OTC: NBMFF ), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce that it has changed its auditors from DeVisser Gray LLP (" Former Auditor ") to MNP LLP (" Successor Auditor "), effective March 19, 2024.

NEO Battery's board of directors accepted the resignation of DeVisser Gray LLP and appointed MNP LLP as the new auditor of the Company, effective March 19, 2024, until the Company's next annual general meeting of shareholders.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Technology Advancement: NEO Battery Expands Production Yield and Capacity with Manufacturing Innovation

T S X V : NBM ) ( OTCQB: NBMFF )

Major Process Innovation Improves Silicon Anode Yield, Capacity, and Particle Uniformity
- Achieved Pilot-Scale Capacity Expansion to 4,000 Kilograms Per Year Without Additional Equipment or Process Change
Participated in Battery Japan and InterBattery 2024 to Establish Over 100 Relationships with EV and Battery Industry Players
Widening Testing Pipeline Partners and Evaluation Scale Towards Larger Battery Capacities and Formats
Appointed Mr. Daniel Lim as Chief Financial Officer

NEO Battery Materials Ltd. (" NEO " or the " C o mpan y "), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to report technological advancements in NEO Battery's silicon anode production yield, capacity, and quality through its recent manufacturing innovation.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

NEO Battery Materials Grants Incentive Stock Options to Management & Engineering Team

T S X V : NBM ) ( OTCQB: NBMFF )

NEO Battery Materials Ltd. (" NEO " or the " C o mpan y "), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, announces that the Company has granted incentive stock options (the " Options ") to certain directors, officers, employees, and consultants to acquire an aggregate of 5,760,000 common shares, in accordance with the Company's 10% rolling stock option plan.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that a detailed biomarker analysis of the recently reported pre-clinical melanoma study conducted at Dalhousie University (the "Study") indicates that, beyond shrinking tumors on its own, Sona's Targeted Hyperthermia Therapy ("THT") also stimulates the innate immune system to target and eliminate untreated (contralateral) tumors when combined with a standard immunotherapeutic drug, IL-2. (See figure #1, below.) On the basis of efficacy data achieved in two different murine cancer models (triple negative breast cancer and malignant melanoma), the Company is now proceeding with safety and biocompatibility testing that will be required by regulating agencies to enter into human studies.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

PRINCIPAL TECHNOLOGIES ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT

Principal Technologies Inc. (the " Company ") (TSXV: PTEC) (FSE: J07), is pleased to announce the closing of the first tranche (" Tranche 1 ") of its previously announced non-brokered private placement (the " Offering ") with one investor, MRPT Invest UG (" MRPT "), a company owned and controlled by Markus Mair . The Company issued a total of 4,000,000 units at $0.25 per unit for gross proceeds of $1,000,000 . Each unit (a " Unit ") will consist of one common share (a ' Share ") of the Company and one common share purchase warrant (a " Warrant "). Each Warrant entitles the holder to purchase one additional Share of the Company at $0.30 for a period of two (2) years from the date of closing. The Warrants are subject to a blocker term that prohibits exercise of the Warrants to the extent the holder would as a result of any exercise exceed 19.99% of then issued Shares.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that its targeted hyperthermia therapy ("THT") demonstrated positive results in a second preclinical cancer model. Findings just presented at the 2024 STING & TLR Targeted Therapies Summit for immunotherapies in San Diego, California, show that Sona's THT achieved responses in a preclinical melanoma model equal to that which was recently reported from its triple negative breast cancer study. THT effectively treated melanoma tumors in all animals when administered on its own. Further, when THT was combined with doses of interleukin-2 ("IL-2"), a standard immunotherapy, a synergistic effect was shown whereby greater treatment response, measured by tumor volume reduction, was achieved in comparison to either approach alone.